CharlesGavoty

Partner

Paris + 33.1.56.59.39.39

Recognized as a leading lawyer, Charles Gavoty serves clients in the hi-tech, biotech, medtech, and fintech industries in matters relating to capital markets, mergers and acquisitions, venture capital, and private equity. He represents a large number of emerging companies and their managers or investors in transactions ranging from seed to late-stage financing, private and public M&A deals, IPOs, private placements, and rights issues, to corporate structuring and management compensation packages.

Representative of Charles's work is his involvement in Completel's friendly takeover by Altice for $1 billion; the successful defense of Wavecom against Gemalto's hostile bid and the subsequent friendly takeover of Wavecom by Sierra Wireless; the sale of Novexel to AstraZeneca for US$505 million; the sales of Capitain Train, We Are Cloud, MobPartner, Movea, and Ipdia; the IPO of Inside Secure, SuperSonic Imagine, and Tronics; the equity lines of Cellectis, Inside Secure, and Carmat; the convertible bonds (Oceanes) issue of Inside Secure; the last financing rounds of Frichti, Alkemics, and DataBerries; and the investment by Benchmark, NJJ, and Idinvest in Zenly.

Charles's other recent representations of tech/biotech companies include Alkemics, Carmat, Cellectis, Clustree, Criteo, Databerries, Frichti, Inside Secure, Happn, Novexel, Orange, SAP, Slimpay, Stratumn, SuperSonic Imagine, Theranexus, Veolia, and Voltalia, and, on the investors' side, Alven, Benchmark, Bpi, Hi Inov, Idinvest, Index, Kima, Korelya, Kreaxi, NJJ, Omnes Capital, Otium, Partech, Seventure, Sofinnova, Valar, and XAnge.

In 2001, he received the Lavoisier Scholarship awarded by the French Ministry of Foreign Affairs.

Experience

  • TreeFrog Therapeutics raises €64 million in Series B financing roundJones Day represented TreeFrog Therapeutics, a privately held French-based biotech startup focused on developing safe and affordable stem cell-derived cell therapies for millions of patients, in connection with its €64 million Series B financing round led by Bpifrance Large Venture and joined by Leonard Green & Partners L.P., Bristol Myers Squibb, and XAnge.
  • Modjo raises €7 million in Series A roundJones Day advised Modjo in its €7 million Series A financing round with participation from Daphni fund, business angels, and the Aglaé Ventures fund
  • Elephant leads $40 million Series B financing round of DidomiJones Day represented Elephant as a lead investor with Breega in the $40 million Series B financing of Didomi, a Paris-based consent and preference management platform for collecting and leveraging user consents and preferences for businesses.
  • Singular Capital Partners leads €8.6 million investment in FairmatJones Day advised Singular Capital Partners in the €8.6 million seed round of financing of Fairmat, a Paris, France-based manufacturer of new kinds of industrial products out of material waste.
  • Alkemics sells company to SalsifyJones Day advised Alkemics SAS and its shareholders in the sale of the company to Salsify, Inc., which empowers brands by providing tools to track and analyze inventories, presentation, and sales of goods on digital shelves.
  • Back Market raises $335 million in Series D roundJones Day advised Back Market, a French company specialized in the development and exploitation of an online marketplace dedicated to refurbished products, in connection with its $335 million Series D round of financing led by General Atlantic with the support of Generation Investment Management as well as existing investors.
  • HealthHero acquires QareJones Day advised HealthHero in its acquisition of Qare, a French platform that provides medical video consultation services, backed by Kamet Ventures.
  • Elephant participates in €30 million Series B financing round of DataDomeJones Day represented Elephant as lead investor in the €30 million Series B round of financing of DataDome, a French leading bot protection vendor.
  • Singular Capital Partners leads €5 million financing round of ResilienceJones Day advised Singular Capital Partners in connection with the €5 million financing round of Resilience, a French-based company engaged in the development of digital solutions in oncology for patients, caregivers, and pharmaceutical laboratories.
  • Alven Capital, Bpifrance, Serena Capital, the management, and other main shareholders sell Lengow to Marlin Equity PartnersJones Day advised Alven Capital Partners, Bpifrance, Serena Capital, the management, and other main shareholders of Lengow, a French company that develops an e-commerce automation SaaS platform, in connection with its sale to Marlin Equity Partners.
  • XAnge leads €2.6 million financing round of Core BiogenesisJones Day advised XAnge in connection with the €2.6 million financing round of Core Biogenesis, a French company engaged in the development of processes using plants as biofactories to produce growth factors and other recombinant proteins.
  • Indy.fr (formerly Georges.Tech) raises €35 million in Series B financing roundJones Day advised Indy.fr (formerly Georges.Tech), a French-based company engaged in the design, development, editing and management of accounting software, along with the participating investors Singular Capital Partners, Alven Capital Partners, and Kerala, in connection with Indy.fr's €35 million Series B round of financing.
  • Easyrecrue sells company to iCIMS, Inc.Jones Day represented management and shareholders of Easyrecrue in connection with the sale of the company, a European leader in video interviewing and digital assessment capabilities, to iCIMS, Inc.
  • Ringo raises initial capital for companyJones Day represented Ringo SAS, a French company developing and marketing conversational analysis software (Saas), in connection with the seed financing round led by a French investment fund alongside business angels.
  • Joko raises €10 million in Series A financing roundJones Day advised Joko, a French-based fintech developing a cashback app that rewards users every time they spend using their bank card, in connection with its €10 million Series A round of financing.
  • Unlatch raises €5.2 million in financing roundJones Day advised Unlatch, a French company that is engaged in the business of automation of contracts, provision of a CRM, and communication management software in order to accelerate real estate sales, in connection with its €5.2 million financing round led by AXA Venture Partners.
  • Partech Ventures, Omnes Capital, XAnge, and Korelya Capital invest in AB TastyJones Day represented Partech, Omnes, XAnge, and Korelya Capital in connection with their participation in a $40 million Series C financing of AB Tasty, a French-based platform specialized in web A/B testing and customer experience optimization, led by Crédit Mutuel Innovation.
  • Alkemics raises €21 million in financing roundJones Day represented Alkemics SAS, a platform enabling brands to launch products with retailers, in connection with the €21 million financing round led by a UK-based VC fund together with existing investors.
  • Ring Capital, SEB Alliance, Amundi Finance et Solidarité, and Raise Impact participate in €13.5 million financing round of CastalieJones Day represented Ring Capital, SEB Alliance, Amundi Finance et Solidarité, and Raise Impact in connection with the €13.5 million round of financing of Castalie, a French company engaged in the development, manufacturing, and marketing of water fountains and water cooling.
  • Kalray receives €8 million investment from NXP Semiconductors N.V.Jones Day assisted Kalray, a pioneer in processors for new intelligent systems, in connection with the €8 million strategic investment from NXP Semiconductors N.V., enables companies to develop together safe, reliable, and scalable solutions for autonomous driving.
  • Additional Publications

    • June 28, 2004
      Vers une extension de l'obligation de renégocation en matière contractuelle ?, Petites Affiches
    • November 17, 2003
      La loi de securite financiere: une loi d'insecurite juridique, Option Finance
    • August - September 2001
      L'absorption par une societe par actions simplifiee exige-t-elle le consentement unaime des associes de la sciete aborbee? Bulletin Joly Societes

    Speaking Engagements

    • January 29, 2013
      Le Private Equity : où en sommes-nous ?
    • May 2007
      Strategic Negotiations, panelist, INSEAD
    • Annually 2005-2013
      The Management Package, ESSEC Business School